Youmanitarian
11 Jun 2021
Immunotherapy breakthrough in Hodgkin lymphoma patients | Dana-Farber Cancer Institute
6 Просмотры
TAKE ACTION
Donations would go to support charities for
How-to & Style
Eighty-seven percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission, reported in a study published in the New England Journal of Medicine and presented at the annual meeting of the American Society of Hematology.
Показать больше
More ways to take action
Explore ways that you can help bring a solution to this issue.
Create Youms with hashtags How-to & Style
Create a challenge to bring awareness to this issue for people to complete
Create a fundraiser to support a charity that tackle this issue
Volunteer at charitable organization that support this cause
Create a movement page dedicated to this cause to bring awareness.
Start a uCharity for this cause and invite people to join it to support this cause
